Oxygerolan 40 mg - Retardtabletten
Recall
|
Medicines
|
27/08/2020
The marketing authorisation holder informed its customers on August 27, 2020 that the specified active ingredient content cannot be guaranteed in each individual tablet.
Therefore, the concerned batch will be recalled.
Name of the medicinal product | Oxygerolan 40 mg - Retardtabletten |
---|---|
Marketing authorisation number(s) | 1-29622 |
CIP code | 3775492 |
Marketing authorisation holder | G.L. Pharma GmbH |
Batch number(s) | 9F119A |
Classification of the recall | 2 |
Depth of recall | Pharmacies |
BASG reference number | INS-640.001-3297 |
Further inquiry note
Page last modified:
27/08/2020